Extraction Technologies for Medicinal and Aromatic ... - Capacity4Dev
Extraction Technologies for Medicinal and Aromatic ... - Capacity4Dev
Extraction Technologies for Medicinal and Aromatic ... - Capacity4Dev
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
14 QUALITY CONTROL OF MEDICINAL AND AROMATIC PLANTS AND THEIR EXTRACTED PRODUCTS<br />
BY HPLC AND HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY<br />
14.3 Biological <strong>and</strong> Chemical St<strong>and</strong>ardization<br />
of Drugs<br />
All test procedures ultimately aim to determine the intrinsic potency<br />
of a drug, which is attributable to the chemical constituents present.<br />
Evaluating the biological potency of a drug provides a direct assessment<br />
of its quality. But, the complexity of the procedures <strong>and</strong> methods <strong>for</strong>bids<br />
implying this assessment. Moreover, it is not the practical option when one<br />
h<strong>and</strong>les large numbers of samples. The other option, besides biological<br />
testing, is chemical testing, which uses assay procedures to determine the<br />
quantity of chemical compounds, preferably the active ones, to assess the<br />
quality of a product. This is complementary to recording other specifi cations<br />
like macro- <strong>and</strong> microscopic characteristics.<br />
14.3.1 Chemical St<strong>and</strong>ardization <strong>and</strong> Markers<br />
Chemical st<strong>and</strong>ardization requires fi rst to identify <strong>and</strong> select a<br />
chemical constituent of a drug <strong>and</strong> then to elaborate the assay procedure<br />
<strong>for</strong> quantifi cation of the chosen compound. Selection of the constituent,<br />
called marker, is a diffi cult task based on several considerations: the chemical<br />
profi le of the drug, biological activity of the chemical constituents, successful<br />
development of the assay procedure, ease of procuring or isolating<br />
the marker, <strong>and</strong> stability of the marker.<br />
The European Union Guidelines defi ne markers as “Chemically<br />
defi ned constituents or groups of constituents of a herbal substance, a<br />
herbal preparation or a herbal medicinal product which are of interest <strong>for</strong><br />
control purposes independent of whether they have any therapeutic activity.”<br />
The WHO defi nes markers as “constituents of a medicinal plant material<br />
which are chemically defi ned <strong>and</strong> of interest <strong>for</strong> control purposes.”<br />
Markers serve to calculate the quantity of herbal substances or<br />
herbal preparations in the herbal medicinal product if the marker has been<br />
quantitatively determined in the herbal substance or herbal preparations. The<br />
European Medicines Agency differentiates an active marker from an analytical<br />
marker: an active marker contributes to the therapeutic activity of the drug,<br />
whereas an analytical marker serves only the analytical purposes.<br />
The choice of a marker, in first place, should be <strong>for</strong> a chemical<br />
constituent of the drug responsible <strong>for</strong> the activity. More than one marker can<br />
be employed <strong>for</strong> control purposes, separately or in combination. A second<br />
choice of marker is <strong>for</strong> a defined chemical constituent that is uniquely associated<br />
with the drug. This is true when active constituents of the drug are<br />
not known or active constituents are unobtainable or unstable <strong>for</strong> assay purposes.<br />
As a last choice, a marker can be selected among more commonly or<br />
ubiquitously present phytoconstituents. In rare cases, a chemical compound<br />
242